Abstract
FASTKD2 encodes an RNA-binding protein, which is a key post-transcriptional regulator of mitochondrial gene expression. Mutations in FASTKD2 have recently been found in mitochondrial encephalomyopathy, which is characterized by a deficiency in mitochondrial function. To date, seven patients have been reported. Six patients were identified with nonsense or frameshift mutations in the FASTKD2 gene, and only one patient harbored a missense mutation and a nonsense mutation. Here, we identified a novel FASTKD2 homozygous mutation, c.911 T > C, in a patient diagnosed with Lennox-Gastaut syndrome. We observed that the expression of FASTKD2 and the levels of mitochondrial 16 S rRNA were lower in the patient than in the unaffected controls. In conclusion, the missense mutation c.911 T > C caused loss of function in FASTKD2, which was associated with a new phenotype, Lennox-Gastaut syndrome.
Your institute does not have access to this article
Access options
Subscribe to Journal
Get full journal access for 1 year
$119.00
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.



References
Ohkubo A, Van Haute L, Rudler DL, Stentenbach M, Steiner FA, Rackham O. et al. The FASTK family proteins fine-tune mitochondrial RNA processing. Plos Genet. 2021;17:e1009873. https://doi.org/10.1371/journal.pgen.1009873.
Popow J, Alleaume AM, Curk T, Schwarzl T, Sauer S, Hentze MW. FASTKD2 is an RNA-binding protein required for mitochondrial RNA processing and translation. RNA. 2015;21:1873–84. https://doi.org/10.1261/rna.052365.115.
Jourdain AA, Popow J, de la Fuente MA, Martinou JC, Anderson P, Simarro M. The FASTK family of proteins: emerging regulators of mitochondrial RNA biology. Nucleic Acids Res. 2017;45:10941–7. https://doi.org/10.1093/nar/gkx772.
Boehm E, Zaganelli S, Maundrell K, Jourdain AA, Thore S, Martinou JC. FASTKD1 and FASTKD4 have opposite effects on expression of specific mitochondrial RNAs, depending upon their endonuclease-like RAP domain. Nucleic Acids Res. 2017;45:6135–46. https://doi.org/10.1093/nar/gkx164.
Boehm E, Zornoza M, Jourdain AA, Delmiro Magdalena A, García-Consuegra I, Torres Merino R. et al. Role of FAST Kinase Domains 3 (FASTKD3) in Post-transcriptional regulation of mitochondrial gene expression. J Biol Chem. 2016;291:25877–87. https://doi.org/10.1074/jbc.M116.730291.
Jourdain AA, Koppen M, Rodley CD, Maundrell K, Gueguen N, Reynier P. et al. A mitochondria-specific isoform of FASTK is present in mitochondrial RNA granules and regulates gene expression and function. Cell Rep. 2015;10:1110–21. https://doi.org/10.1016/j.celrep.2015.01.063.
Ghezzi D, Saada A, D’Adamo P, Fernandez-Vizarra E, Gasparini P, Tiranti V. et al. FASTKD2 nonsense mutation in an infantile mitochondrial encephalomyopathy associated with cytochrome c oxidase deficiency. Am J Hum Genet. 2008;83:415–23. https://doi.org/10.1016/j.ajhg.2008.08.009.
Simarro M, Gimenez-Cassina A, Kedersha N, Lazaro JB, Adelmant GO, Marto JA. et al. Fast kinase domain-containing protein 3 is a mitochondrial protein essential for cellular respiration. Biochem Biophys Res Commun. 2010;401:440–6. https://doi.org/10.1016/j.bbrc.2010.09.075.
Lee I, Hong W. RAP-a putative RNA-binding domain. Trends Biochem Sci. 2004;29:567–70. https://doi.org/10.1016/j.tibs.2004.09.005.
Das S, Yeung KT, Mahajan MA, Samuels HH. Fas Activated Serine-Threonine Kinase Domains 2 (FASTKD2) mediates apoptosis of breast and prostate cancer cells through its novel FAST2 domain. BMC Cancer. 2014;14:852. https://doi.org/10.1186/1471-2407-14-852
Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J. et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24. https://doi.org/10.1038/gim.2015.30.
Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc. 2006;1:581–5. https://doi.org/10.1038/nprot.2006.83.
Wei X, Du M, Li D, Wen S, Xie J, Li Y. et al. Mutations in FASTKD2 are associated with mitochondrial disease with multi-OXPHOS deficiency. Hum Mutat. 2020;41:961–72. https://doi.org/10.1002/humu.23985.
Yoo DH, Choi YC, Nam DE, Choi SS, Kim JW, Choi BO. et al. Identification of FASTKD2 compound heterozygous mutations as the underlying cause of autosomal recessive MELAS-like syndrome. Mitochondrion. 2017;35:54–58. https://doi.org/10.1016/j.mito.2017.05.005.
Benkirane M, Marelli C, Guissart C, Roubertie A, Ollagnon E, Choumert A. et al. High rate of hypomorphic variants as the cause of inherited ataxia and related diseases: study of a cohort of 366 families. Genet Med. 2021;23:2160–70. https://doi.org/10.1038/s41436-021-01250-6.
Arzimanoglou A, French J, Blume WT, Cross JH, Ernst JP, Feucht M. et al. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology. Lancet Neurol. 2009;8:82–93. https://doi.org/10.1016/S1474-4422(08)70292-8.
Lee S, Baek MS, Lee YM. Lennox-Gastaut syndrome in mitochondrial disease. Yonsei Med J. 2019;60:106–14. https://doi.org/10.3349/ymj.2019.60(1).1.106.
Antonicka H, Shoubridge EA. Mitochondrial RNA granules are centers for posttranscriptional rna processing and ribosome biogenesis. Cell Rep. 2015;10:920–32. https://doi.org/10.1016/j.celrep.2015.01.030.
Perks KL, Rossetti G, Kuznetsova I, Hughes LA, Ermer JA, Ferreira N. et al. PTCD1 is required for 16s rrna maturation complex stability and mitochondrial ribosome assembly. Cell Rep. 2018;23:127–42. https://doi.org/10.1016/j.celrep.2018.03.033.
Acknowledgements
We thank the patients and their families for their participation in the study. We would like to thank Editage (www.editage.cn) for the English language editing.
Author information
Authors and Affiliations
Contributions
TW drafted the manuscript and performed the experiments. LM and FY performed patient clinical management and analyzed the clinical data. CC analyzed the EEG data. JP supervised the work and designed of the research.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval
This study was approved by the Ethics Committee of Xiangya Hospital of Central South University, China (Human study/protocol #201605585).
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Wu, T., Mao, L., Chen, C. et al. A novel homozygous missense mutation in the FASTKD2 gene leads to Lennox-Gastaut syndrome. J Hum Genet (2022). https://doi.org/10.1038/s10038-022-01056-7
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s10038-022-01056-7